Sight Diagnostics will develop and produce a portable malaria and complete blood count (CBC) reader, which will be calibrated and tested in clinical trials at the USAMRD-K Field Station in Kisumu, Kenya.
Currently, SightDx is marketing Parasight device, which is a malaria detection platform that uses computer vision technology to analyze blood samples for malaria parasites.
The advanced cytometry technology aggregates computer vision algorithms, custom optics, and proprietary disposable cartridges for analyzing blood samples.
SightDx intends to develop and test a portable version of the malaria diagnostic technology that can provide complete blood count and additional diagnostic information for health care providers operating in remote locations.
The next generation device is expected to scan a single cartridge of five tests, in contrast to the current device that can hold 30 tests and features automated loading and scanning.
The project will be carried out in collaboration with USAMRD-K Basic Science Laboratory chief and senior scientist Dr John Waitumbi.
SightDx CEO Yossi Pollak said: We are very excited about the partnership with USAMRD-K. This award recognizes SightDx's success in bringing a high-throughput computer vision malaria diagnostic technology to the market and sets us on a path to launch a point of care version of the platform in remote locations and austere environments.
“USAMRD-K in Kisumu, Kenya serves as an ideal partner, given their extensive background in malaria clinical research and expertise in malaria diagnostics."
